Furthermore, pro-angiogenic factors SEMA4D, EGLN1, and FOXK2 were down-regulated after N3a-treatment, with ECM1 demonstrating the lowest expression level in MCL. This evidence concerns the gene EGLN1 and mantle cell lymphoma.